Home / News / Product News

New Arrival: Aspirel "The Dual Action Sweepng Agent"


Aspirel is a fixed dose combination containing Clopidogrel and Aspirin. Aspirel Tablet is already available in the market. Clopidogrel is an inhibitor of platelet aggregation. Clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor and the subsequent ADP Mediated activation of the glycoprotein GPllblllla complex, thereby inhibiting platelet aggregation. Aspirin is also an antiplatelet agent. It acts by causing irreversible inhibition of the cyclo-oxygenase enzyme.

Aspirel is indicated for the prevention of atherosclerotic events in patients with the history of symptomatic atherosclerotic diseases (ischemic stroke, myocardial infarction or acute coronary syndrome).